The essential resource for your practice
Volume XXI, Number
AUA Urges Lawmakers to Preserve In-Office Ancillary Exception
Medicare cost-savings through elimination of the in-office ancillary exception (IOAE) has been a topic of conversation on Capitol Hill in recent weeks. Protecting a physician's relationship with their patients is at the top of the AUA legislative agenda, and the association is actively working with lawmakers to protect a physician's right to personally provide these services to patients.
Table of Contents
AUA Plans ICD-10 Training for Urology Practices
CMS Launches Revised Physican Compare; Feedback Required by July 5
On Thursday, June 27, the Centers for Medicare & Medicaid Services (CMS) launched its revised Physician Compare website. The purpose of Physician Compare is to help patients make informed choices about the healthcare they receive through Medicare. The website allows the public to research physicians and other healthcare professionals enrolled in the Medicare program.
The redesign includes new information on physicians, such as:
Information about specialties offered by doctors and group practices;
Whether a physician is using electronic health records or participates in the Physician Quality Reporting System (PQRS);
Board certification; and
Affiliation with hospitals and other health care professionals.
CMS is seeking feedback on the Physician Compare through Friday, July 5, 2013. The AUA urges its members to visit Physician Compare immediately and test the website. Your comments will prove critical to future iterations of the program, especially as CMS hopes to increase the information displayed. see more>>
FDA Issues Recall on AFX Introducer System
Recently the Food and Drug Administration (FDA) announced that Endologix, Inc. initiated a recall of its AFX Introducer System Model S17-45 due to reports of the dilator breaking during procedures.This product is intended to help introduce catheters and other medical devices into blood vessels during procedures with minimal blood loss. This recalled product was distributed and manufactured from April 1, 2013, through April 30, 2013, and distributed in the US only in Florida, Indiana, Michigan, New Hampshire, New Jersey and New York. Affected lot numbers include 1079840, 1079843, 1079844, 1079845. No other Endologix products are being recalled or affected at this time.
AUA Helps Drive Obesity Reclassification
Obesity is a condition that affects more than 90 million Americans. In an effort to encourage Americans to seek active treatment for obesity, the American Medical Association (AMA), at their June Annual Meeting of the House of Delegates, declared obesity a disease.
This highly debated resolution, introduced by the American Association of Clinical Endocrinologists (AACE), was supported by the Urology Delegationandthe American College of Cardiology (ACC).
Dr. Jeffrey Mechanick, President of the AACE commented on the resolution saying, “The new AMA policy recognizing obesity as a disease state creates a medical model for obesity, just like there are for diseases such as diabetes and hypertension. This represents a paradigm shift that will remove the stigma of obesity as a lifestyle choice and create greater access to care including screening, early intervention and treatment, and better training of healthcare professionals.”